fda update on semaglutide FDA's Removal of and the Evolving Tirzepatide Decisions: What Compounders Need to Know The FDA's Decision to Ban

Last reviewed: June 27, 2026 Last updated: June 27, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

If you're looking for a reliable source for high-quality compounded semaglutide, Ivy Rx provides expertly formulated options to help you stay on track

Safe & Effective: This treatment is a non-invasive option for individuals struggling to lose weight

Are not tolerated by all skin types

We've actually even had to hire extra people just to help with the coverage of the phone calls, messages, the prior authorizations, the appeals that are needed just for this medication class," Peavie said

The legal framework allows their sale and purchase, but therapeutic use falls outside regulatory approval